Current treatment of dysfunctional uterine bleeding.
OBJECTIVE
We performed a review of the treatment modalities for dysfunctional uterine bleeding.


METHODS
Dysfunctional uterine bleeding can be treated medically or surgically. Medical treatment consists of anti-fibrinolytic tranexamic acid, non-steroidal anti-inflammatory drugs, the combined contraception pill, progestogen, danazol, or analogues of gonadotrophin releasing hormone. The levonorgestrel releasing intra uterine device is developed for contraception, but is also effective in the treatment of dysfunctional uterine bleeding. Surgical treatment includes endometrial ablation of the first and second-generation, and hysterectomy. This review contains current available evidence on the effectiveness of these therapies.


RESULTS
Antifibrinolytic tranexamic acid is the most effective medical therapy to treat dysfunctional uterine bleeding. In general medical therapy is not as effective as endometrial resection in terms of patient satisfaction and health related quality of life. The levonorgestrel releasing intra uterine device is an effective treatment for dysfunctional uterine bleeding. No difference in quality of life was observed in patients treated with a levonorgestrel releasing intra uterine device as compared to hysterectomy. Ablation techniques of the first generation are effective and safe when used by trained surgeons, but have a learning curve. Ablation techniques of the second generation are effective, but long-term follow-up data are not available. Similarly, there are no large randomised controlled trials comparing the levonorgestrel releasing intra uterine device to first and second-generation ablation techniques. Hysterectomy, the traditional standard of care, has a relatively high complication rate, but it generates a high satisfaction rate and good health related quality of life scores.


CONCLUSIONS
Since none of the treatments for dysfunctional bleeding is superior to one of the others, and since all treatments have their advantages and disadvantages, counselling of patients with dysfunctional bleeding should incorporate medical approach, levonorgestrel releasing IUD, endometrial ablation and hysterectomy.
Bongers
Marlies Y
MY
Department of Obstetrics and Gynaecology, Máxima Medical Centre, P.O. Box 7777, 5500 MB Veldhoven, The Netherlands. my.bongers@iae.nl
Mol
Ben W J
BW
Brölmann
Hans A M
HA
D017115:Catheter Ablation; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003376:Counseling; D004717:Endometrium / Q000601:surgery*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D015907:Hysteroscopy / Q000379:methods; D007436:Intrauterine Devices, Medicated; D010535:Laparoscopy; D053685:Laser Therapy; D016912:Levonorgestrel / Q000008:administration & dosage*; D011788:Quality of Life; D014592:Uterine Hemorrhage / Q000628:therapy*; D014621:Vagina
D003271:Contraceptive Agents, Female; D016912:Levonorgestrel